Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLST vs ACDT for Submassive PE
NCT03581877Phase 4Active, not recruiting
- Sponsor
- Northwell Health
- Start
- Jan 2019
- Primary completion
- Mar 2023
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tissue-plasminogen activator in pulmonary embolism (PE), sponsored by Northwell Health. Started Jan 2019; status: active, not recruiting.
02
Drugs
tissue-plasminogen activator
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT03581877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03581877.